cell therapy production process

IRI: https://spec.industrialontologies.org/ontology/construct/CellTherapyProductionProcess

Defined In: https://spec.industrialontologies.org/ontology/biopharma/BiopharmaManufacturingExecution/

SubClass Of: biomanufacturing production process

Class Hierarchy

owl:Thing β€Ί bfo:entity β€Ί bfo:occurrent β€Ί bfo:process β€Ί planned process β€Ί manufacturing process β€Ί biomanufacturing production process β€Ί cell therapy production process

Definition

biomanufacturing production process that results in a cell population which constitutes the targeted product material

Examples

  • manufacturing of autologous CAR-T cell therapy through patient-derived T-cell activation and expansion in culture bags; large-scale allogeneic NK-cell expansion in single-use bioreactors for immunotherapy

Adapted From

  • https://www.cellandgene.com/topic/cell-therapy-manufacturing and https://www.fda.gov/media/156896/download

Primitive Class

This class is declared primitive and it does not have necessary and sufficient condiftions defined.

Primitive Rationale

There are insufficient constructs to create a set of necessary and sufficient conditions. In particular constructs for representing cells as the target product are still missing.

Formal Axioms

First-Order Logic Axioms

CellTherapyProductionProcess(x) β†’ BiomanufacturingProductionProcess(x) ∧ βˆƒo ((MaterialProduct(o) ∨ ProcessIntermediateMaterial(o)) ∧ hasSpecifiedOutput(x, o) ∧ βˆƒp (CulturedCellPopulation(p) ∧ hasContinuantPartAtAllTimes(o, p)))

Semi-Formal Natural Language Axioms

if x is a β€˜cell therapy production process’ then x is a β€˜biomanufacturing production process’ that β€˜has specified output’ some β€˜material product’ or some β€˜process intermediate material’ that β€˜has continuant part at all times’ some β€˜cultured cell population’

Description Logic


Back to top

Copyright © 2024–2026 Open Applications Group / Industrial Ontology Foundry. Distributed under an MIT license.